Vikor Scientific

Based in Charleston, South Carolina, Vikor Scientific is an molecular diagnostics company that utilizes advanced diagnostic solutions to rapidly identify and quantify pathogens and reveal resistance genes contributing to antibiotic resistance. Vikor aims to improve overall treatment effectiveness and fight the global epidemic of antibiotic resistance, ultimately improving patient and economic outcomes.

Vikor has designed customized molecular diagnostic panels and has the capability to deliver precise pathogen detection and quantification data within 12 to 24 hours of the specimen arriving at Vikor. In addition to delivering results more rapidly than with conventional culture techniques, the molecular diagnostic tests are three to five times more sensitive, leading to an improved overall accuracy.

Vikor Scientific has created ABXAssist™, a proprietary, interpretive diagnostic test report that provides an individualized approach to antibiotic selection. This algorithm and reporting platform not only supports the delivery and analysis of the molecular laboratory results, but is also accompanied by individualized pharmacy access and guidance. Vikor believes an accurate result is only the first step in creating a successful treatment plan for a patient. Providers must also consider patient allergies, age, comorbidities, pharmacodynamics, costs, public databases demonstrating sensitivity and susceptibility data, FDA guidance and antibiotic spectra. Vikor believes in a team approach to meet these demands and has hired a team of doctors of pharmacy to assist providers in reaching an end solution that can truly improve their patients' outcomes.